Clusterin serum levels are elevated in patients with early rheumatoid arthritis and predict disease activity and treatment response

Clusterin (CLU) is a molecular chaperone that participates in a variety of biological processes. Recent studies indicate its possible involvement in the development of bone erosions and autoimmunity. The aim of this study was to investigate its serum concentrations in patients with early rheumatoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Kropáčková, Tereza, Mann, Heřman, Růžičková, Olga, Šléglová, Olga, Vernerová, Lucia, Horváthová, Veronika, Tomčík, Michal, Pavelka, Karel, Vencovský, Jiří, Šenolt, Ladislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169772/
https://www.ncbi.nlm.nih.gov/pubmed/34075162
http://dx.doi.org/10.1038/s41598-021-90973-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169772/
https://www.ncbi.nlm.nih.gov/pubmed/34075162
http://dx.doi.org/10.1038/s41598-021-90973-2

Ejemplares similares